Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai Berner

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Molecular Diagnosis & Therapy|March 1, 2020
Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer DetectionMarc Hirschfeld, Gerta Rücker, Daniela Weiß, et al.
Cancers|May 11, 2024
Real-World Data Analysis of CDK4/6 Inhibitor Therapy-A Patient-Centric Single Center StudyIsabell Ge, Kai Berner, Marlene Mathis, et al.
Endocrine Connections|October 28, 2020
Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteinsJasmin Asberger, Thalia Erbes, Markus Jaeger, et al.
Experimental and Therapeutic Medicine|January 31, 2025
Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?Jasmin Asberger, Isabell Ge, Benjamin Schmidt, et al.
Archives of Gynecology and Obstetrics|December 10, 2021
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control studyKai Berner, Marc Hirschfeld, Daniela Weiß, et al.
International Journal of Oncology|December 3, 2019
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?Andrea Ritter, Marc Hirschfeld, Kai Berner, et al.
Biomedicines|October 28, 2023
In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast CancerJasmin Asberger, Kai Berner, Anna Bicker, et al.
Cancer Biomarkers : Section a of Disease Markers|February 22, 2020
Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancerAndrea Ritter, Marc Hirschfeld, Kai Berner, et al.
Breast Cancer (Dove Medical Press)|December 17, 2021
Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitroAnna-Lena Klauser, Marc Hirschfeld, Andrea Ritter, et al.
Molecular Medicine Reports|October 1, 2020
Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitroMarc Hirschfeld, Isabel Ge, Gerta Rücker, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecular Diagnosis & Therapy|March 1, 2020
Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer DetectionMarc Hirschfeld, Gerta Rücker, Daniela Weiß, et al.
Cancers|May 11, 2024
Real-World Data Analysis of CDK4/6 Inhibitor Therapy-A Patient-Centric Single Center StudyIsabell Ge, Kai Berner, Marlene Mathis, et al.
Endocrine Connections|October 28, 2020
Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteinsJasmin Asberger, Thalia Erbes, Markus Jaeger, et al.
Experimental and Therapeutic Medicine|January 31, 2025
Long non‑coding RNA signatures in breast cancer: Properties as biomarkers?Jasmin Asberger, Isabell Ge, Benjamin Schmidt, et al.
Archives of Gynecology and Obstetrics|December 10, 2021
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control studyKai Berner, Marc Hirschfeld, Daniela Weiß, et al.
International Journal of Oncology|December 3, 2019
Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?Andrea Ritter, Marc Hirschfeld, Kai Berner, et al.
Biomedicines|October 28, 2023
In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast CancerJasmin Asberger, Kai Berner, Anna Bicker, et al.
Cancer Biomarkers : Section a of Disease Markers|February 22, 2020
Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancerAndrea Ritter, Marc Hirschfeld, Kai Berner, et al.
Breast Cancer (Dove Medical Press)|December 17, 2021
Anticarcinogenic Effects of Odorant Substances Citral, Citrathal R and Cyclovertal on Breast Cancer in vitroAnna-Lena Klauser, Marc Hirschfeld, Andrea Ritter, et al.
Molecular Medicine Reports|October 1, 2020
Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitroMarc Hirschfeld, Isabel Ge, Gerta Rücker, et al.
Pageof 2